{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:59:14Z","timestamp":1785794354968,"version":"3.56.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02264-x","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:06:39Z","timestamp":1738926399000},"page":"3264-3281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic Efficacy of Intermittent Ketogenesis in Modulating Adenosine Metabolism, Immune Response, and Seizure Severity in Refractory Temporal Lobe Epilepsy: A Pilot Human Study"],"prefix":"10.1007","volume":"48","author":[{"given":"Seyyed Hossein","family":"Khatami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Alehossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Ehtiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayebe","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Salmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Bagherzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Razmafrooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Rajabibazl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Shahmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza Faghih","family":"Jouibari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Tafakhori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Karima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"8","key":"2264_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S1474-4422(23)00151-5","volume":"22","author":"E Perucca","year":"2023","unstructured":"Perucca, E., P. Perucca, H. S. White, and E. C. Wirrell. 2023. Drug resistance in epilepsy. The Lancet Neurology 22 (8): 723\u2013734.","journal-title":"The Lancet Neurology"},{"issue":"11","key":"2264_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41582-020-00419-y","volume":"16","author":"H Lerche","year":"2020","unstructured":"Lerche, H. 2020. Drug-resistant epilepsy\u2014time to target mechanisms. Nature Reviews Neurology 16 (11): 595\u2013596.","journal-title":"Nature Reviews Neurology"},{"issue":"1","key":"2264_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1212\/CON.0000000000000297","volume":"22","author":"D R Nair","year":"2016","unstructured":"Nair, D. R. 2016. Management of drug-resistant epilepsy. CONTINUUM: Lifelong Learning in Neurology 22 (1): 157\u2013172.","journal-title":"CONTINUUM: Lifelong Learning in Neurology"},{"key":"2264_CR4","unstructured":"Karimzadeh P., Tabarestani S., Shamsabadi,\u00a0Mahvelati\u00a0F., Tonekaboni S.H., Ghofrani Mohsen.\u00a02009. Intractable seizure disorders: efficacy of the classic ketogenic diet. Iranian Journal of child neurology (IJCN)[Internet] 3 (1): 15\u201320."},{"issue":"3","key":"2264_CR5","first-page":"12","volume":"8","author":"A Ghazavi","year":"2014","unstructured":"Ghazavi, A., S. H. Tonekaboni, P. Karimzadeh, A. A. Nikibakhsh, A. Khajeh, and A. Fayyazi. 2014. The ketogenic and Atkins diets effect on intractable epilepsy: A comparison. Iranian Journal of Child Neurology. 8 (3): 12.","journal-title":"Iranian Journal of Child Neurology."},{"key":"2264_CR6","unstructured":"Alaei, M., Reza, Ghazavi, M., Mahvelati, F., Karimzadeh, P., Reza, Shiva, M., and S. Tonekaboni Hassan. 2010. The effect of the ketogenic diet on the growth and biochemical parameters of the children with resistant epilepsy. Iranian Journal of Child Neurology 3 (4):41\u20134."},{"issue":"4","key":"2264_CR7","first-page":"83","volume":"13","author":"P Karimzadeh","year":"2019","unstructured":"Karimzadeh, P., T. Moosavian, and H. R. Moosavian. 2019. Effects of a formula-based ketogenic diet on refractory epilepsy in 1 to 3 year-old patients under classic ketogenic diet. Iranian Journal of Child Neurology 13 (4): 83.","journal-title":"Iranian Journal of Child Neurology"},{"issue":"3","key":"2264_CR8","first-page":"7","volume":"13","author":"P Karimzadeh","year":"2019","unstructured":"Karimzadeh, P., and A. Tabrizi. 2019. A journey of dietary therapies for epilepsy in iran: Diet restriction in the ancient era to the ketogenic diet in the modern period. Iranian Journal of Child Neurology 13 (3): 7.","journal-title":"Iranian Journal of Child Neurology"},{"key":"2264_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00415-019-09658-6","volume":"267","author":"S Green","year":"2020","unstructured":"Green, S., P. Nguyen, K. Kaalund-Hansen, S. Rajakulendran, and E. Murphy. 2020. Effectiveness, retention, and safety of modified ketogenic diet in adults with epilepsy at a tertiary-care centre in the UK. Journal of Neurology 267: 1171\u20131178.","journal-title":"Journal of Neurology"},{"issue":"6","key":"2264_CR10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.seizure.2014.02.015","volume":"23","author":"M Nei","year":"2014","unstructured":"Nei, M., L. Ngo, J. I. Sirven, and M. R. Sperling. 2014. Ketogenic diet in adolescents and adults with epilepsy. Seizure 23 (6): 439\u2013442.","journal-title":"Seizure"},{"issue":"1","key":"2264_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/2319-4170.107154","volume":"36","author":"Y M Liu","year":"2013","unstructured":"Liu, Y. M., and H. S. Wang. 2013. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomedical Journal 36 (1): 9\u201315.","journal-title":"Biomedical Journal"},{"issue":"4","key":"2264_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/braincomms\/fcab160","volume":"3","author":"N E Schoeler","year":"2021","unstructured":"Schoeler, N. E., M. Orford, U. Vivekananda, Z. Simpson, B. Van de Bor, H. Smith, et al. 2021. K. Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy. Brain Communications 3 (4): 160.","journal-title":"Brain Communications"},{"issue":"5","key":"2264_CR13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","volume":"50","author":"E G Neal","year":"2009","unstructured":"Neal, E. G., H. Chaffe, R. H. Schwartz, M. S. Lawson, N. Edwards, G. Fitzsimmons, et al. 2009. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 50 (5): 1109\u20131117.","journal-title":"Epilepsia"},{"issue":"8","key":"2264_CR14","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/epi.16972","volume":"62","author":"F Y Han","year":"2021","unstructured":"Han, F. Y., L. Conboy-Schmidt, G. Rybachuk, H. A. Volk, B. Zanghi, Y. Pan, et al. 2021. Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies. Epilepsia 62 (8): 1790\u20131806.","journal-title":"Epilepsia"},{"key":"2264_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuropharm.2012.11.004","volume":"69","author":"P Chang","year":"2013","unstructured":"Chang, P., N. Terbach, N. Plant, P. E. Chen, M. C. Walker, and R. S. Williams. 2013. Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology 69: 105\u2013114.","journal-title":"Neuropharmacology"},{"issue":"1","key":"2264_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tins.2012.11.005","volume":"36","author":"A Lutas","year":"2013","unstructured":"Lutas, A., and G. Yellen. 2013. The ketogenic diet: Metabolic influences on brain excitability and epilepsy. Trends in Neurosciences 36 (1): 32\u201340.","journal-title":"Trends in Neurosciences"},{"key":"2264_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.clnesp.2023.01.024","volume":"54","author":"N Arora","year":"2023","unstructured":"Arora, N., S. Pulimamidi, H. Yadav, S. Jain, J. Glover, K. Dombrowski, et al. 2023. Intermittent fasting with ketogenic diet: A combination approach for management of chronic diseases. Clinical Nutrition ESPEN 54: 166\u2013174.","journal-title":"Clinical Nutrition ESPEN"},{"issue":"13","key":"2264_CR18","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/foods13131960","volume":"13","author":"S Brogi","year":"2024","unstructured":"Brogi, S., R. Tabanelli, S. Puca, and V. Calderone. 2024. Intermittent fasting: myths, fakes and truth on this dietary regimen approach. Foods 13 (13): 1960.","journal-title":"Foods"},{"issue":"1","key":"2264_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-nutr-071816-064634","volume":"37","author":"R E Patterson","year":"2017","unstructured":"Patterson, R. E., and D. D. Sears. 2017. Metabolic effects of intermittent fasting. Annual Review of Nutrition 37 (1): 371\u2013393.","journal-title":"Annual Review of Nutrition"},{"issue":"1","key":"2264_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1186\/s12877-022-03521-6","volume":"22","author":"P Giannos","year":"2022","unstructured":"Giannos, P., K. Prokopidis, I. Lidoriki, K. K. Triantafyllidis, K. S. Kechagias, K. Celoch, et al. 2022. Medium-chain triglycerides may improve memory in non-demented older adults: A systematic review of randomized controlled trials. BMC Geriatrics 22 (1): 817.","journal-title":"BMC Geriatrics"},{"issue":"2","key":"2264_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3233\/JAD-230406","volume":"94","author":"L Sun","year":"2023","unstructured":"Sun, L., K. X. Ye, H. L. K. Wong, L. Wang, S. L. Lim, Y. X. Chao, et al. 2023. The effects of medium chain triglyceride for Alzheimer\u2019s disease related cognitive impairment: A systematic review and meta-analysis. Journal of Alzheimer\u2019s Disease 94 (2): 441\u2013456.","journal-title":"Journal of Alzheimer's Disease"},{"key":"2264_CR22","first-page":"329","volume":"41","author":"Y Gupta","year":"1997","unstructured":"Gupta, Y., and J. Malhotra. 1997. Adenosinergic system as an endogenous anticonvulsant mechanism. Indian Journal of Physiology and Pharmacology 41: 329\u2013343.","journal-title":"Indian Journal of Physiology and Pharmacology"},{"issue":"1","key":"2264_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/ijms22010320","volume":"22","author":"J Spanoghe","year":"2020","unstructured":"Spanoghe, J., L. E. Larsen, E. Craey, S. Manzella, A. Van Dycke, P. Boon, et al. 2020. The signaling pathways involved in the anticonvulsive effects of the adenosine A1 receptor. International Journal of Molecular Sciences. 22 (1): 320.","journal-title":"International Journal of Molecular Sciences."},{"key":"2264_CR24","first-page":"1380","volume":"5","author":"C V Gomes","year":"1808","unstructured":"Gomes, C. V., M. P. Kaster, A. R. Tom\u00e9, and P. M. Agostinho. 1808. Cunha RA (2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochimica et Biophysica Acta (BBA)-Biomembranes 5: 1380\u20131399.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"2264_CR25","doi-asserted-by":"publisher","first-page":"1152667","DOI":"10.3389\/fphar.2023.1152667","volume":"14","author":"N R Shi","year":"2023","unstructured":"Shi, N. R., Q. Wang, J. Liu, J. Z. Zhang, B. L. Deng, X. M. Hu, et al. 2023. Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy. Frontiers in Pharmacology 14: 1152667.","journal-title":"Frontiers in Pharmacology"},{"issue":"12","key":"2264_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.tips.2006.10.008","volume":"27","author":"D Boison","year":"2006","unstructured":"Boison, D. 2006. Adenosine kinase, epilepsy and stroke: Mechanisms and therapies. Trends in Pharmacological Sciences 27 (12): 652\u2013658.","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"2264_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1528-1167.2011.03306.x","volume":"53","author":"M De Groot","year":"2012","unstructured":"De Groot, M., A. Iyer, E. Zurolo, J. Anink, J.J. Heimans, D. Boison, et al. 2012. Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-associated epilepsy. Epilepsia 53 (1): 58\u201366.","journal-title":"Epilepsia"},{"issue":"5","key":"2264_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/ATVBAHA.106.126714","volume":"27","author":"M L\u00f6ffler","year":"2007","unstructured":"L\u00f6ffler, M., J.C. Morote-Garcia, S. A. Eltzschig, I. R. Coe, and H. K. Eltzschig. 2007. Physiological roles of vascular nucleoside transporters. Arteriosclerosis, Thrombosis, and Vascular Biology 27 (5): 1004\u20131013.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"2264_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s42494-021-00059-9","volume":"3","author":"R Chen","year":"2021","unstructured":"Chen, R., G. Xue, and C. H\u00f6lscher. 2021. The role of the TNF\u03b1-mediated astrocyte signaling pathway in epilepsy. Acta Epileptologica 3 (1): 24.","journal-title":"Acta Epileptologica"},{"key":"2264_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2015.01.009","volume":"26","author":"I F Uludag","year":"2015","unstructured":"Uludag, I. F., T. Duksal, B. I. Tiftikcioglu, Y. Zorlu, F. Ozkaya, and G. Kirkali. 2015. IL-1\u03b2, IL-6 and IL1Ra levels in temporal lobe epilepsy. Seizure. 26: 22\u201325.","journal-title":"Seizure."},{"key":"2264_CR31","doi-asserted-by":"publisher","first-page":"102335","DOI":"10.1016\/j.pneurobio.2022.102335","volume":"217","author":"J Yue","year":"2022","unstructured":"Yue, J., R. Xu, C. Yin, H. Yang, C. Zhang, and D. Zhao. 2022. Negative effects of brain regulatory T cells depletion on epilepsy. Progress in Neurobiology 217: 102335.","journal-title":"Progress in Neurobiology"},{"key":"2264_CR32","first-page":"203","volume":"19","author":"D Xu","year":"2021","unstructured":"Xu, D., S. Koh, and S.D. Miller. 2021. Role of Regulatory T cells in Epilepsy. Inflammation and Epilepsy: New Vistas. 19: 203\u201319.","journal-title":"Inflammation and Epilepsy: New Vistas."},{"issue":"3","key":"2264_CR33","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s12035-022-02725-6","volume":"59","author":"A Soltani Khaboushan","year":"2022","unstructured":"Soltani Khaboushan, A., N. Yazdanpanah, and N. Rezaei. 2022. Neuroinflammation and proinflammatory cytokines in epileptogenesis. Molecular Neurobiology. 59 (3): 1724\u20131743.","journal-title":"Molecular Neurobiology."},{"key":"2264_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2017.01.016","volume":"37","author":"N Magdalinou","year":"2017","unstructured":"Magdalinou, N., A. Noyce, R. Pinto, E. Lindstrom, J. Holm\u00e9n-Larsson, M. Holtta, et al. 2017. Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics. Parkinsonism & Related Disorders 37: 65\u201371.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"2264_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0920-1211(02)00003-7","volume":"48","author":"J A Cramer","year":"2002","unstructured":"Cramer, J. A., G. A. Baker, and A. Jacoby. 2002. Development of a new seizure severity questionnaire: Initial reliability and validity testing. Epilepsy Research 48 (3): 187\u2013197.","journal-title":"Epilepsy Research"},{"key":"2264_CR36","doi-asserted-by":"publisher","first-page":"108506","DOI":"10.1016\/j.yebeh.2021.108506","volume":"128","author":"M Hatami","year":"2022","unstructured":"Hatami, M., H. S. Moghaddam, A. Tafakhori, L. Sahebi, S. Vaziri, P. Panahi, et al. 2022. Psychometric evaluation of Persian version of Seizure Severity Questionnaire. Epilepsy & Behavior 128: 108506.","journal-title":"Epilepsy & Behavior"},{"issue":"1","key":"2264_CR37","first-page":"809151","volume":"2013","author":"R Azzam","year":"2013","unstructured":"Azzam, R., and N. J. Azar. 2013. Marked seizure reduction after MCT supplementation. Case reports in Neurological Medicine 2013 (1): 809151.","journal-title":"Case reports in Neurological Medicine"},{"issue":"1","key":"2264_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42494-024-00150-x","volume":"6","author":"H Li","year":"2024","unstructured":"Li, H., Y. Wang, J. Guo, P. Zhang, Z. Xu, K. Peng, et al. 2024. Efficacy and safety of modified medium-chain triglyceride ketogenic diet in patients with drug-resistant epilepsy. Acta Epileptologica. 6 (1): 9.","journal-title":"Acta Epileptologica."},{"issue":"6","key":"2264_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/1028415X.2022.2065816","volume":"26","author":"E Rasmussen","year":"2023","unstructured":"Rasmussen, E., V. Patel, S. Tideman, R. Frech, R. Frigerio, and J. Narayanan. 2023. Efficacy of supplemental MCT oil on seizure reduction of adult drug-resistant epilepsy\u2013a single-center open-label pilot study. Nutritional Neuroscience 26 (6): 535\u2013539.","journal-title":"Nutritional Neuroscience"},{"issue":"2","key":"2264_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/brain\/awv325","volume":"139","author":"P Chang","year":"2016","unstructured":"Chang, P., K. Augustin, K. Boddum, S. Williams, M. Sun, J.A. Terschak, et al. 2016. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 139 (2): 431\u2013443.","journal-title":"Brain"},{"issue":"2","key":"2264_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/brain\/awv369","volume":"139","author":"M A Rogawski","year":"2016","unstructured":"Rogawski, M. A. 2016. A fatty acid in the MCT ketogenic diet for epilepsy treatment blocks AMPA receptors. Brain 139 (2): 306\u2013309.","journal-title":"Brain"},{"issue":"1","key":"2264_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin, K., A. Khabbush, S. Williams, S. Eaton, M. Orford, J. H. Cross, et al. 2018. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. The Lancet Neurology. 17 (1): 84\u201393.","journal-title":"The Lancet Neurology."},{"issue":"6","key":"2264_CR43","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jnc.13724","volume":"139","author":"R A Cunha","year":"2016","unstructured":"Cunha, R. A. 2016. How does adenosine control neuronal dysfunction and neurodegeneration? Journal of Neurochemistry. 139 (6): 1019\u20131055.","journal-title":"Journal of Neurochemistry."},{"issue":"14","key":"2264_CR44","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1111\/bph.16094","volume":"181","author":"J A Baltos","year":"2024","unstructured":"Baltos, J. A., P. M. Casillas-Espinosa, B. Rollo, K. J. Gregory, P. J. White, A. Christopoulos, et al. 2024. The role of the adenosine system in epilepsy and its comorbidities. British Journal of Pharmacology. 181 (14): 2143\u20132157.","journal-title":"British Journal of Pharmacology."},{"issue":"1","key":"2264_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neures.2006.05.010","volume":"56","author":"O Pagonopoulou","year":"2006","unstructured":"Pagonopoulou, O., A. Efthimiadou, B. Asimakopoulos, and N. Nikolettos. 2006. Modulatory role of adenosine and its receptors in epilepsy: Possible therapeutic approaches. Neuroscience Research 56 (1): 14\u201320.","journal-title":"Neuroscience Research"},{"issue":"1","key":"2264_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1124\/jpet.114.218768","volume":"352","author":"P Chang","year":"2015","unstructured":"Chang, P., A. M. Zuckermann, S. Williams, A. J. Close, M. Cano-Jaimez, J. P. McEvoy, et al. 2015. Seizure control by derivatives of medium chain fatty acids associated with the ketogenic diet show novel branching-point structure for enhanced potency. Journal of Pharmacology and Experimental Therapeutics 352 (1): 43\u201352.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"2264_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.eplepsyres.2006.10.005","volume":"73","author":"M Dahlin","year":"2007","unstructured":"Dahlin, M., L. Hjelte, S. Nilsson, and P. \u00c5mark. 2007. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Research 73 (2): 199\u2013207.","journal-title":"Epilepsy Research"},{"issue":"10","key":"2264_CR48","doi-asserted-by":"publisher","first-page":"699","DOI":"10.6061\/clinics\/2014(10)09","volume":"69","author":"P A D Lima","year":"2014","unstructured":"Lima, P. A. D., L. P. D. B. Sampaio, and N. R. T. Damasceno. 2014. Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics 69 (10): 699\u2013705.","journal-title":"Clinics"},{"issue":"2","key":"2264_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/caff.2019.0022","volume":"10","author":"F C Tescarollo","year":"2020","unstructured":"Tescarollo, F. C., D. M. Rombo, L. K. DeLiberto, D. E. Fedele, E. Alharfoush, \u00c2. R. Tom\u00e9, et al. 2020. Role of adenosine in epilepsy and seizures. Journal of Caffeine and Adenosine Research 10 (2): 45\u201360.","journal-title":"Journal of Caffeine and Adenosine Research"},{"key":"2264_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/B978-0-12-801022-8.00011-8","volume":"119","author":"S A Masino","year":"2014","unstructured":"Masino, S. A., M. Kawamura Jr., and D. N. Ruskin. 2014. Adenosine receptors and epilepsy: Current evidence and future potential. International Review of Neurobiology 119: 233\u2013255.","journal-title":"International Review of Neurobiology"},{"issue":"8","key":"2264_CR51","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/glia.22285","volume":"60","author":"D Boison","year":"2012","unstructured":"Boison, D. 2012. Adenosine dysfunction in epilepsy. Glia 60 (8): 1234\u20131243.","journal-title":"Glia"},{"issue":"1\u20132","key":"2264_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0006-8993(95)01313-X","volume":"710","author":"M Glass","year":"1996","unstructured":"Glass, M., R. Faull, J. Bullock, K. Jansen, E. Mee, E. Walker, et al. 1996. Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Research 710 (1\u20132): 56\u201368.","journal-title":"Brain Research"},{"issue":"7","key":"2264_CR53","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1046\/j.1528-1157.2003.03603.x","volume":"44","author":"N Gouder","year":"2003","unstructured":"Gouder, N., J. M. Fritschy, and D. Boison. 2003. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44 (7): 877\u2013885.","journal-title":"Epilepsia"},{"issue":"1","key":"2264_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.expneurol.2004.12.012","volume":"193","author":"M G\u00fcttinger","year":"2005","unstructured":"G\u00fcttinger, M., V. Padrun, W. F. Pralong, and D. Boison. 2005. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Experimental Neurology 193 (1): 53\u201364.","journal-title":"Experimental Neurology"},{"key":"2264_CR55","doi-asserted-by":"crossref","unstructured":"Rumney RM, G\u00f3recki DC. Knockout and knock-in mouse models to study purinergic signaling. InPurinergic Signaling: Methods and Protocols 2019 Oct 24 (pp. 17\u201343). New York, NY: Springer New York.","DOI":"10.1007\/978-1-4939-9717-6_2"},{"issue":"2","key":"2264_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/imt.15.106","volume":"8","author":"D Allard","year":"2016","unstructured":"Allard, D., B. Allard, P. O. Gaudreau, P. Chrobak, and J. Stagg. 2016. CD73\u2013adenosine: A next-generation target in immuno-oncology. Immunotherapy 8 (2): 145\u2013163.","journal-title":"Immunotherapy"},{"issue":"1","key":"2264_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12929-021-00766-y","volume":"28","author":"C P Chang","year":"2021","unstructured":"Chang, C. P., K. C. Wu, C. Y. Lin, and Y. Chern. 2021. Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases. Journal of Biomedical Science 28 (1): 70.","journal-title":"Journal of Biomedical Science"},{"issue":"8","key":"2264_CR58","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1007\/s12035-023-03351-6","volume":"60","author":"M Guo","year":"2023","unstructured":"Guo, M., J. Zhang, J. Wang, X. Wang, Q. Gao, C. Tang, et al. 2023. Aberrant adenosine signaling in patients with focal cortical dysplasia. Molecular Neurobiology 60 (8): 4396\u20134417.","journal-title":"Molecular Neurobiology"},{"key":"2264_CR59","doi-asserted-by":"publisher","first-page":"105441","DOI":"10.1016\/j.nbd.2021.105441","volume":"157","author":"E Augusto","year":"2021","unstructured":"Augusto, E., F. Q. Gon\u00e7alves, J. E. Real, H. B. Silva, D. Pochmann, T. S. Silva, et al. 2021. Increased ATP release and CD73-mediated adenosine A2A receptor activation mediate convulsion-associated neuronal damage and hippocampal dysfunction. Neurobiology of Disease 157: 105441.","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"2264_CR60","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1523\/JNEUROSCI.4781-03.2004","volume":"24","author":"N Gouder","year":"2004","unstructured":"Gouder, N., L. Scheurer, J. M. Fritschy, and D. Boison. 2004. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. Journal of Neuroscience 24 (3): 692\u2013701.","journal-title":"Journal of Neuroscience"},{"issue":"9","key":"2264_CR61","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/j.1528-1167.2011.03115.x","volume":"52","author":"E Aronica","year":"2011","unstructured":"Aronica, E., E. Zurolo, A. Iyer, M. De Groot, J. Anink, C. Carbonell, et al. 2011. Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia 52 (9): 1645\u20131655.","journal-title":"Epilepsia"},{"issue":"10","key":"2264_CR62","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/brain\/awh555","volume":"128","author":"D E Fedele","year":"2005","unstructured":"Fedele, D. E., N. Gouder, M. G\u00fcttinger, L. Gabernet, L. Scheurer, T. R\u00fclicke, et al. 2005. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain 128 (10): 2383\u20132395.","journal-title":"Brain"},{"issue":"3","key":"2264_CR63","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1528-1167.2010.02947.x","volume":"52","author":"P Theofilas","year":"2011","unstructured":"Theofilas, P., S. Brar, K. A. Stewart, H. Y. Shen, U. S. Sandau, D. Poulsen, et al. 2011. Adenosine kinase as a target for therapeutic antisense strategies in epilepsy. Epilepsia 52 (3): 589\u2013601.","journal-title":"Epilepsia"},{"key":"2264_CR64","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s11064-016-1893-1","volume":"41","author":"J Huang","year":"2016","unstructured":"Huang, J., M. N. Chen, J. Du, H. Liu, Y. J. He, G. L. Li, et al. 2016. Differential expression of adenosine P1 receptor ADORA1 and ADORA2A associated with glioma development and tumor-associated epilepsy. Neurochemical Research 41: 1774\u20131783.","journal-title":"Neurochemical Research"},{"key":"2264_CR65","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1007\/s12035-017-0850-6","volume":"55","author":"F P Menezes","year":"2018","unstructured":"Menezes, F. P., F. Machado Torresini, L. R. Nery, and R. S. da Silva. 2018. Transient disruption of adenosine signaling during embryogenesis triggers a pro-epileptic phenotype in adult zebrafish. Molecular Neurobiology 55: 6547\u20136557.","journal-title":"Molecular Neurobiology"},{"key":"2264_CR66","doi-asserted-by":"crossref","unstructured":"Canas PM, Porci\u00fancula LO, Sim\u00f5es AP, Augusto E, Silva HB, Machado NJ, Gon\u00e7alves N, Alfaro TM, Gon\u00e7alves FQ, Ara\u00fajo IM, Real JI. 2018. Neuronal adenosine A2A receptors are critical mediators of neurodegeneration triggered by convulsions. Eneuro 5(6).","DOI":"10.1523\/ENEURO.0385-18.2018"},{"issue":"2","key":"2264_CR67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.phrs.2007.04.011","volume":"56","author":"N Hosseinmardi","year":"2007","unstructured":"Hosseinmardi, N., J. Mirnajafi-Zadeh, Y. Fathollahi, and P. Shahabi. 2007. The role of adenosine A1 and A2A receptors of entorhinal cortex on piriform cortex kindled seizures in rats. Pharmacological Research 56 (2): 110\u2013117.","journal-title":"Pharmacological Research"},{"issue":"1\u20132","key":"2264_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.eplepsyres.2012.02.012","volume":"100","author":"C Moschovos","year":"2012","unstructured":"Moschovos, C., G. Kostopoulos, and C. Papatheodoropoulos. 2012. Endogenous adenosine induces NMDA receptor-independent persistent epileptiform discharges in dorsal and ventral hippocampus via activation of A2 receptors. Epilepsy Research 100 (1\u20132): 157\u2013167.","journal-title":"Epilepsy Research"},{"key":"2264_CR69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fphar.2018.00627","volume":"9","author":"M Pastor-Anglada","year":"2018","unstructured":"Pastor-Anglada, M., and S. P\u00e9rez-Torras. 2018. Who is who in adenosine transport. Frontiers in Pharmacology 9: 627.","journal-title":"Frontiers in Pharmacology"},{"key":"2264_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-014-8338-2","volume":"17","author":"Z Xu","year":"2015","unstructured":"Xu, Z., P. Xu, Y. Chen, J. Liu, Y. Zhang, Y. Lv, et al. 2015. ENT1 inhibition attenuates epileptic seizure severity via regulation of glutamatergic neurotransmission. Neuromolecular Medicine 17: 1\u201311.","journal-title":"Neuromolecular Medicine"},{"key":"2264_CR71","first-page":"1","volume":"23","author":"Z Xiong","year":"2024","unstructured":"Xiong, Z., J. Deng, P. Xie, C. Tang, J. Wang, Q. Deng, Y. Yang, J. Zhang, M. Guo, X. Wang, and Y. Guan. 2024. Deep Brain Stimulation Inhibits Epileptic Seizures via Increase of Adenosine Release and Inhibition of ENT1, CD39, and CD73 Expression. Molecular Neurobiology 23: 1\u20133.","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"2264_CR72","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/epi.14674","volume":"60","author":"U S Sandau","year":"2019","unstructured":"Sandau, U. S., M. Yahya, R. Bigej, J. L. Friedman, B. Saleumvong, and D. Boison. 2019. Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice. Epilepsia 60 (4): 615\u2013625.","journal-title":"Epilepsia"},{"issue":"2","key":"2264_CR73","first-page":"571","volume":"118","author":"T Li","year":"2008","unstructured":"Li, T., G. Ren, T. Lusardi, A. Wilz, J.Q. Lan, T. Iwasato, et al. 2008. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. The Journal of Clinical Investigation 118 (2): 571\u2013582.","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"2264_CR74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.12170","volume":"259","author":"K S Smigiel","year":"2014","unstructured":"Smigiel, K. S., S. Srivastava, J. M. Stolley, and D. J. Campbell. 2014. Regulatory T-cell homeostasis: Steady-state maintenance and modulation during inflammation. Immunological Reviews 259 (1): 40\u201359.","journal-title":"Immunological Reviews"},{"issue":"4","key":"2264_CR75","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1084\/jem.20171285","volume":"215","author":"D Xu","year":"2018","unstructured":"Xu, D., A. P. Robinson, T. Ishii, D. A. S. Duncan, T. D. Alden, G. E. Goings, et al. 2018. Peripherally derived T regulatory and \u03b3\u03b4 T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy. Journal of Experimental Medicine 215 (4): 1169\u20131186.","journal-title":"Journal of Experimental Medicine"},{"key":"2264_CR76","unstructured":"Li, C., Ma, W.-N., and H. Wang. 2011. Changes of regulatory T cells in the peripheral blood of children with epilepsy. Zhongguo dang dai er ke za zhi= Chinese Journal of Contemporary Pediatrics 13 (11):889\u201392."},{"key":"2264_CR77","doi-asserted-by":"crossref","unstructured":"Hendrix, E., Vande, Vyver, M., Holt, M., and I. Smolders. 2024. Regulatory T cells as a possible new target in epilepsy?. Epilepsia.","DOI":"10.1111\/epi.18038"},{"key":"2264_CR78","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/epi.13785","volume":"58","author":"M L Barker-Haliski","year":"2017","unstructured":"Barker-Haliski, M. L., W. L\u00f6scher, H. S. White, and A. S. Galanopoulou. 2017. Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy. Epilepsia 58: 39\u201347.","journal-title":"Epilepsia"},{"key":"2264_CR79","doi-asserted-by":"crossref","unstructured":"Lach P, Klus W, Zajdel K, Szeleszczuk A, Komorowska E, Burda K, Kurowski P.\u00a02022. Neuroinflammation in epilepsy\u2014diagnostics and therapeutic perspectives. Current Pharmacology Reports 1\u20135.","DOI":"10.1007\/s40495-021-00270-9"},{"issue":"10","key":"2264_CR80","first-page":"1760","volume":"21","author":"A N Kamali","year":"2021","unstructured":"Kamali, A. N., Z. Zian, J. M. Bautista, H. Hamedifar, N. Hossein-Khannazer, R. Hosseinzadeh, et al. 2021. The potential role of pro-inflammatory and anti-inflammatory cytokines in epilepsy pathogenesis. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 21 (10): 1760\u20131774.","journal-title":"Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)"},{"issue":"38","key":"2264_CR81","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.2174\/1381612811319380009","volume":"19","author":"L Lorigados Pedre","year":"2013","unstructured":"Lorigados Pedre, L., L. M. Morales Chacon, S. Orozco Su\u00e1rez, N. Pavon Fuentes, B. Estupinan Diaz, T. Serrano S\u00e1nchez, et al. 2013. Inflammatory mediators in epilepsy. Current Pharmaceutical Design 19 (38): 6766\u20136772.","journal-title":"Current Pharmaceutical Design"},{"key":"2264_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1192-7","volume":"15","author":"A Rana","year":"2018","unstructured":"Rana, A., and A. E. Musto. 2018. The role of inflammation in the development of epilepsy. Journal of Neuroinflammation 15: 1\u201312.","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"2264_CR83","first-page":"3030625","volume":"2023","author":"M Peltola","year":"2023","unstructured":"Peltola, M., P. Basnyat, S. Liimatainen, S. Rainesalo, M. Pesu, and J. Peltola. 2023. The regulation of plasma interleukin-6 levels is modified by hippocampal sclerosis and its lateralization in drug-resistant temporal lobe epilepsy. Acta Neurologica Scandinavica 2023 (1): 3030625.","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"2264_CR84","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.nbd.2006.06.003","volume":"24","author":"T Ravizza","year":"2006","unstructured":"Ravizza, T., K. Boer, S. Redeker, W. Spliet, P. Van Rijen, D. Troost, et al. 2006. The IL-1\u03b2 system in epilepsy-associated malformations of cortical development. Neurobiology of Disease 24 (1): 128\u2013143.","journal-title":"Neurobiology of Disease"},{"key":"2264_CR85","doi-asserted-by":"crossref","unstructured":"Patel DC, Wallis G, Dahle EJ, McElroy PB, Thomson KE, Tesi RJ, Szymkowski DE, West PJ, Smeal RM, Patel M, Fujinami RS.\u00a02017. Hippocampal TNF\u03b1 signaling contributes to seizure generation in an infection-induced mouse model of limbic epilepsy. Eneuro 4(2).","DOI":"10.1523\/ENEURO.0105-17.2017"},{"key":"2264_CR86","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.expneurol.2013.01.011","volume":"247","author":"M S Weinberg","year":"2013","unstructured":"Weinberg, M. S., B. L. Blake, and T. J. McCown. 2013. Opposing actions of hippocampus TNF\u03b1 receptors on limbic seizure susceptibility. Experimental Neurology 247: 429\u2013437.","journal-title":"Experimental Neurology"},{"issue":"1","key":"2264_CR87","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41387-023-00246-2","volume":"13","author":"S Li","year":"2023","unstructured":"Li, S., Y. Du, C. Meireles, K. Sharma, L. Qi, A. Castillo, et al. 2023. Adherence to ketogenic diet in lifestyle interventions in adults with overweight or obesity and type 2 diabetes: A scoping review. Nutrition & Diabetes 13 (1): 16.","journal-title":"Nutrition & Diabetes"},{"issue":"1","key":"2264_CR88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-nutr-111120-111518","volume":"41","author":"P Puchalska","year":"2021","unstructured":"Puchalska, P., and P.A. Crawford. 2021. Metabolic and signaling roles of ketone bodies in health and disease. Annual Review of Nutrition 41 (1): 49\u201377.","journal-title":"Annual Review of Nutrition"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02264-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02264-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02264-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:03:43Z","timestamp":1762880623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02264-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":88,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2264"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02264-x","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were carried out with approval and oversight from the Ethics Committee of Shahid Beheshti University of Medical Sciences (SBMU; reference number: IR.SBMU.MSP.REC.1401.613). The trial was registered prospectively in the Iranian Registry of Clinical Trials (IRCT), a primary registry in the World Health Organization's registry network (URL:\n                      \n                      ), under identifier number IRCT20170315033086N11. All participants provided written informed consent by signing an authorization form before enrolling in the research. Informed consent protected participants' autonomy and rights throughout their involvement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All the authors agreed on the final version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}